Associated Papers
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS et al.
Blood Advances, 2024
38315878 (PubMed )
Supplement: BLOODA_ADV-2023-010906-mmc1.pdf
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.
Geier CB et al.
Journal of Clinical Immunology, 2022
35947323 (PubMed )
Supplement: 10875_2022_1312_MOESM4_ESM.xlsx › CXCR4
Select a paper to view details